News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Gilead Sciences, Inc. (GILD) Allows China/Indian Pharmas To Make Generic Version Of Novel HIV Drug



7/30/2014 8:49:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

July 29, 2014 -- Gilead Sciences will allow China and Indian drugmakers to start developing generic formulations of a promising novel HIV/HBV drug, even though the drug’s Phase III tests are still underway. The drug, tenofovir alafenamide (TAF), is a prodrug of the well-known antiretroviral HIV treatment Viread (tenofovir), which is also a Gilead product. China/Indian generic pharmas will be able to market TAF in 112 developing countries – countries that are home to more than 90% of the world’s HIV patients.

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES